From What's New: A Life-Extension Drug for Big Dogs Is Getting Closer to Reality

A San Francisco biotech company is developing a life-extension drug for large dog breeds, aiming to increase their longevity and well-being. The drug has received positive feedback from the FDA and targets a hormone linked to dog size. The podcast explores genetic factors in canine longevity, including breed-specific versions and the discovery of the ERBB-4 gene, with potential impacts for human health and ethical considerations.